Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Inclusion Criteria: * Written informed consent * Female or male, 18 to 65 years of age and in good general health * Clinical diagnosis of stable mild to moderate atopic dermatitis * Willing and able to follow study instructions and likely to complete all study requirements Exclusion Criteria: * Severe or uncontrolled asthma * Pregnant, nursing, or planning a pregnancy during the study; or is a WOCBP but is not willing to use an effective method of birth control * Current enrollment in an investigational drug or device study or participation in such a study within the last 30 days prior to Baseline (Day 0)